Tags:BioTechBuildingDevelopmentIndustryInformationNetworksPlatformProductWebsite
Neurona is a biotherapeutics company developing neural cell therapies with single-dose curative potential for the treatment of chronic neurological disorders. Based on a novel neural cell lineage pioneered by the company’s scientific founders, Neurona has built a robust regenerative platform and is developing neuronal, glial, and gene-edited cell therapy candidates that provide long-term repair of dysfunctional neural networks for multiple neurological disorders. For more information about Neurona visit our website.
Location: United States, California, South San Francisco
Member count: 11-50
Total raised: $72.6M

Investors 2

Funding Rounds 3

DateSeriesAmountInvestorsDeal News
22.06.2021-$41.5M--
01.12.2015Series A$23.5M--
24.12.2014-$7.6M--

Mentions in press and media 7

DateTitleDescriptionCategoryAuthorSource
13.10.2021Digital he...CVS Health turning drugstores ...-Kristin Ka...vator.tv/n...
07.10.2021Daily fund...Neumora Therapeutics raised $5...-Kristin Ka...vator.tv/n...
22.06.2021Neurona Th...Syndicate includes premier hea...--marketscre...
02.12.2015Daily fund...ORIC Pharmaceuticals bagged $5...-Mitos Suso...vator.tv/n...
02.12.2015Neurona ge...The idea, says interim CEO Tim...--medcitynew...
01.12.2015Neurona Th...Neurona Therapeutics Inc., a S...USA-finsmes.co...
24.12.2014Stem cells...Also listed is Leo Guthart, a ...--medcitynew...